| Barlow Malin, MSN, CRNA | |
|
1900 N Higley Rd, Gilbert, AZ 85234-1604 | |
| (480) 543-2000 | |
| Not Available |
| Full Name | Barlow Malin |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 1900 N Higley Rd, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144751371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 240244 (Arizona) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 6970 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Anesthesiology Consultants Inc | 4880591841 | 371 |
News Archive
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Hartford Hospital, one of the nation's "Most Wired" hospitals, is collaborating with NextGate in a Health Information Exchange (HIE) implementation and a separate work-flow integration project. With an aim to improve patient care, both initiatives rely on NextGate's MatchMetrix indexing solution to uniquely identify a patient across multiple encounters and locations within the Hartford healthcare system and beyond.
UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
| Entity Name | Valley Anesthesiology Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285660704 PECOS PAC ID: 4880591841 Enrollment ID: O20031217000620 |
News Archive
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Hartford Hospital, one of the nation's "Most Wired" hospitals, is collaborating with NextGate in a Health Information Exchange (HIE) implementation and a separate work-flow integration project. With an aim to improve patient care, both initiatives rely on NextGate's MatchMetrix indexing solution to uniquely identify a patient across multiple encounters and locations within the Hartford healthcare system and beyond.
UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
| Entity Name | Greater Anesthesia Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124430244 PECOS PAC ID: 9234357906 Enrollment ID: O20140822000525 |
News Archive
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Hartford Hospital, one of the nation's "Most Wired" hospitals, is collaborating with NextGate in a Health Information Exchange (HIE) implementation and a separate work-flow integration project. With an aim to improve patient care, both initiatives rely on NextGate's MatchMetrix indexing solution to uniquely identify a patient across multiple encounters and locations within the Hartford healthcare system and beyond.
UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
| Entity Name | Arlington Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023483153 PECOS PAC ID: 2860798303 Enrollment ID: O20200306000876 |
News Archive
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Hartford Hospital, one of the nation's "Most Wired" hospitals, is collaborating with NextGate in a Health Information Exchange (HIE) implementation and a separate work-flow integration project. With an aim to improve patient care, both initiatives rely on NextGate's MatchMetrix indexing solution to uniquely identify a patient across multiple encounters and locations within the Hartford healthcare system and beyond.
UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barlow Malin, MSN, CRNA 645 E Missouri Ave, Ste 300, Phoenix, AZ 85012-1351 Ph: (602) 262-8917 | Barlow Malin, MSN, CRNA 1900 N Higley Rd, Gilbert, AZ 85234-1604 Ph: (480) 543-2000 |
News Archive
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Hartford Hospital, one of the nation's "Most Wired" hospitals, is collaborating with NextGate in a Health Information Exchange (HIE) implementation and a separate work-flow integration project. With an aim to improve patient care, both initiatives rely on NextGate's MatchMetrix indexing solution to uniquely identify a patient across multiple encounters and locations within the Hartford healthcare system and beyond.
UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
› Verified 1 days ago
Mr. Timothy Joe Carter Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 N. Higley Road, Gilbert, AZ 85234 Phone: 480-981-2400 Fax: 480-981-2407 | |
Timothy Randall Strong, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-534-2600 Fax: 480-543-2586 | |
Alisha Howe, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1833 E Everglade Ln, Gilbert, AZ 85298 Phone: 602-592-6144 | |
Nicole Amber Dewitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4331 E Baseline Rd, Suite B105-625, Gilbert, AZ 85234 Phone: 480-981-0216 Fax: 480-981-1151 | |
Brandon David Brewer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2600 | |
Jennifer Baker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2600 |